Inventor · disambiguated record
Laurie H. Glimcher
Also filed as: GLIMCHER LAURIE H
41 granted patents·29 pending applications·335 citations·filing 1993–2024
98Inventor score
Files withHARVARD COLLEGE36GLIMCHER LAURIE H12UNIV CORNELL10DANA FARBER CANCER INST INC6HOTAMISLIGIL GOKHAN S1
Top patents by PatentIndex Score
70 records- 0188US6274338B1Human c-Maf compositions and methods of use thereofHARVARD COLLEGE·Filed 1998·Granted Aug 14, 2001·55 cites·11 claims
- 0288US5858776ATumor cells with increased immunogenicity and uses thereforHARVARD COLLEGE·Filed 1993·Granted Jan 12, 1999·60 cites·18 claims
- 0386US9957506B2Compounds for inducing anti-tumor immunity and methods thereofUNIV CORNELL·Filed 2014·Granted May 1, 2018·6 cites·10 claims
- 0486US8227184B2Methods for modulating de novo hepatic lipogenesis by modulating XBP-1 activityGLIMCHER LAURIE H·Filed 2009·Granted Jul 24, 2012·12 cites·19 claims
- 0585US6149905ATumor cells with increased immunogenicity and uses thereforDANA FARBER CANCER INST INC·Filed 1998·Granted Nov 21, 2000·32 cites·18 claims
- 0683US6632608B2Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activityHARVARD COLLEGE·Filed 2000·Granted Oct 14, 2003·20 cites·26 claims
- 0782US6319709B1Tumor cells with increased immunogenicity and uses thereforHARVARD COLLEGE·Filed 1999·Granted Nov 20, 2001·24 cites·20 claims
- 0881US5958671AMethods and compositions for regulating T cell subsets by modulating transcription factor activityHARVARD COLLEGE·Filed 1996·Granted Sep 28, 1999·30 cites·27 claims
- 0980US10450566B2Compounds for inducing anti-tumor immunity and methods thereofUNIV CORNELL·Filed 2018·Granted Oct 22, 2019·1 cites·19 claims
- 1080US8940479B2Methods for modulating de novo hepatic lipogenesis by modulating XBP-1 activityLEE ANN-HWEE·Filed 2009·Granted Jan 27, 2015·8 cites·50 claims
- 1178US9956236B2Methods for increasing immune responses using agents that directly bind to and activate IRE-1GLIMCHER LAURIE H·Filed 2012·Granted May 1, 2018·3 cites·10 claims
- 1278US8323970B2Modulation of T cell recruitmentGLIMCHER LAURIE H·Filed 2006·Granted Dec 4, 2012·2 cites·9 claims
- 1378US7365169B2T-bet antibodiesHARVARD COLLEGE·Filed 2005·Granted Apr 29, 2008·3 cites·33 claims
- 1478US2025206791A1Use of ire1alpha-xbp1 signaling pathway biomarkers for modulating immune responsesDANA FARBER CANCER INST INC·Filed 2024·Application pending·0 cites
- 1577US7358415B2Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activityHARVARD COLLEGE·Filed 2003·Granted Apr 15, 2008·10 cites·12 claims
- 1676US8026224B2Tumor cells with increased immunogenicity and uses therforDANA FARBER CANCER INST INC·Filed 2005·Granted Sep 27, 2011·1 cites·10 claims
- 1773US10125123B2Small molecule IRE1-α inhibitorsUNIV CORNELL·Filed 2017·Granted Nov 13, 2018·1 cites·14 claims
- 1871US8389792B2Compositions and methods for the treatment and prevention of ulcerative colitis and colon cancer and screening methods to identify sameGLIMCHER LAURIE H·Filed 2010·Granted Mar 5, 2013·2 cites·9 claims
- 1971US6933125B2Human c-Maf compositions and methods of use thereofHARVARD COLLEGE·Filed 2001·Granted Aug 23, 2005·2 cites·25 claims
- 2069US12454572B2Methods of treating anemia in myelodysplastic syndromesDANA FARBER CANCER INST INC·Filed 2022·Granted Oct 28, 2025·0 cites·8 claims
- 2169US8293477B2Methods for modulating bone formation and mineralization by modulating KRC activityGLIMCHER LAURIE H·Filed 2006·Granted Oct 23, 2012·2 cites·9 claims
- 2267US2021238167A1Small molecule ire1-alpha inhibitorsUNIV CORNELL·Filed 2021·Application pending·0 cites
- 2365US12227548B2Use of IRE1α-XBP1 signaling pathway biomarkers for modulating immune responsesDANA FARBER CANCER INST INC·Filed 2019·Granted Feb 18, 2025·0 cites·12 claims
- 2465US7393944B2T-bet compositions and methods of use thereofHARVARD COLLEGE·Filed 2001·Granted Jul 1, 2008·2 cites·38 claims
- 2564US10988461B2Small molecule IRE1-α inhibitorsUNIV CORNELL·Filed 2018·Granted Apr 27, 2021·0 cites·17 claims
- 2664US10421965B2Compounds for inducing anti-tumor immunity and methods thereofUNIV CORNELL·Filed 2018·Granted Sep 24, 2019·0 cites·12 claims
- 2764US2025381241A1Methods and compositions to modulate riok2DANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 2863US2003124103A1Tumor cells with increased immunogenicity and uses thereforFiled 2002·Application pending·0 cites
- 2963US2004024185A1NF-AT-interacting protein NIP45 and methods of use thereforHARVARD COLLEGE·Filed 2003·Application pending·0 cites
- 3062US10655130B2Modulation of breast cancer growth by modulation of XBP1 activityUNIV CORNELL·Filed 2017·Granted May 19, 2020·0 cites·6 claims
- 3162US8685388B2Method for reducing gastro-intestinal inflammation using Bifidobacterium animalis bacteria or a fermented dairy product comprising such bacteriaVEIGA PATRICK·Filed 2009·Granted Apr 1, 2014·1 cites·15 claims
- 3262US7745581B2T-bet compositions and methods of use thereofHARVARD COLLEGE·Filed 2008·Granted Jun 29, 2010·0 cites·15 claims
- 3362US2015018406A1Modulation of breast cancer growth by modulation of xbp1 activityUNIV CORNELL·Filed 2013·Application pending·0 cites
- 3461US8357637B2Molecules involved in regulation of osteoblast activity and osteoclast activity, and methods of use thereofUNIV CORNELL·Filed 2008·Granted Jan 22, 2013·2 cites·8 claims
- 3560US6548734B1Methods relating to modulation of cartilage cell growth and/or differentiation by modulation of NFATp activityHARVARD COLLEGE·Filed 1999·Granted Apr 15, 2003·25 cites·16 claims
- 3659US8048672B2T-bet compositions and methods of use thereofHARVARD COLLEGE·Filed 2002·Granted Nov 1, 2011·3 cites·31 claims
- 3759US2002086421A1Tumor cells with increased immunogenicity and uses thereforUNIV MARYLAND·Filed 2001·Application pending·0 cites
- 3858US6573365B1Antibodies for NF-AT interacting protein, NIP45HARVARD COLLEGE·Filed 2000·Granted Jun 3, 2003·0 cites·3 claims
- 3958US6399322B1Methods and compositions for regulating T cell subsets by modulating transcription factor activityHARVARD COLLEGE·Filed 1999·Granted Jun 4, 2002·7 cites·1 claims
- 4058US2003100114A1Methods for regulating T cell subsets by modulating transcription factor activityHARVARD COLLEGE·Filed 2002·Application pending·0 cites
- 4157US2008241114A1Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activityGLIMCHER LAURIE H·Filed 2008·Application pending·0 cites
- 4257US2008038235A1Methods for regulating T cell subsets by modulating transcription factor activityGLIMCHER LAURIE H·Filed 2006·Application pending·0 cites
- 4356US2009060902A1Methods and compositions for regulating T cell subsets by modulating transcription factor activityHARVARD COLLEGE·Filed 2007·Application pending·0 cites
- 4456US2007009918A1Methods and compositions for regulating T cell subsets by modulating transcription factor activityHARVARD COLLEGE·Filed 2005·Application pending·0 cites
- 4555US2002086305A1Human c-Maf compositions and methods of use thereofHARVARD COLLEGE·Filed 2001·Application pending·0 cites
- 4653US5672473AMethods of identifying compounds useful for treating autoimmune diseasesHARVARD COLLEGE·Filed 1994·Granted Sep 30, 1997·10 cites·25 claims
- 4752US7592147B2Modulation of IL-2 production by T-betHARVARD COLLEGE·Filed 2006·Granted Sep 22, 2009·0 cites·11 claims
- 4852US2005004034A1Human C-Maf compositions and methods of use thereforHARVARD COLLEGE·Filed 2004·Application pending·0 cites
- 4952US2011142799A1Modulation of neurodegenerative disease by modulating xbp-1 activityHARVARD COLLEGE·Filed 2009·Application pending·0 cites
- 5051US7615380B2Methods for modulating an immune response by modulating KRC activityHARVARD COLLEGE·Filed 2003·Granted Nov 10, 2009·2 cites·28 claims
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Laurie H. Glimcher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →